Advertisement
Advertisement
U.S. Markets open in 7 hrs 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

G Medical Innovations Holdings Ltd (GMVD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3859-0.0047 (-1.20%)
At close: 04:00PM EDT
0.3750 -0.01 (-2.82%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3906
Open0.3970
Bid0.0000 x 1000
Ask0.0000 x 800
Day's Range0.3774 - 0.3970
52 Week Range0.3200 - 6.7400
Volume240,366
Avg. Volume2,822,561
Market Cap5.196M
Beta (5Y Monthly)-1.10
PE Ratio (TTM)N/A
EPS (TTM)-0.9160
Earnings DateSep 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results

    The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies The tests offered to the consumers utilize FDA registered componentsTest kit prices range from $50-$260, all provide results within days by CLIA certified labsAdditional testing kits to be announced l

  • GlobeNewswire

    G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price Notification

    Irvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Lis

  • GlobeNewswire

    G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program

    Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, tr

Advertisement
Advertisement